Top news from MedWatch this week
Monday
Lundbeck and partner present ”slam-dunk” data for new Alzheimer’s drug
Analyst: Eli Lilly’s planned study comparing obesity effects with Novo Nordisk will grow the market
Ambu dampens hopes for proclaimed growth driver
Tuesday
Wednesday
Former CEO left Y-mabs with USD 10.7m in severance pay
Thursday
GN, Sonova advance with Veterans Affairs in July – Demant, WSA retreat
Abbvie withdraws from cancer candidate collaboration with Genmab
ALK fears politicians will force pharma industry to foot pandemic bill
Friday
ALK to exit Turkish market: ”It’s bad business if all we get is peanuts”
ALK’s tablet trial in Ukraine set to continue
Genmab postpones crucial cancer candidate decision following Abbvie exit